Skip to main content

Drugs

Ausgabe 4/2021

Inhalt (10 Artikel)

Current Opinion

Understanding the Chameleonic Breakthrough Cancer Pain

Sebastiano Mercadante, Russell K. Portenoy

Leading Article

Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis

Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez

Review Article

Novel Therapy Approaches to Follicular Lymphoma

Michael Northend, William Townsend

Open Access Adis Drug Evaluation

Secukinumab: A Review in Psoriatic Arthritis

Hannah A. Blair

AdisInsight Report

BNT162b2 mRNA COVID-19 Vaccine: First Approval

Yvette N. Lamb

AdisInsight Report

Orelabrutinib: First Approval

Sohita Dhillon

AdisInsight Report

Tirbanibulin: First Approval

Anthony Markham, Sean Duggan

Aktuelle Ausgaben